Search for: "Schering Corporation"
Results 1 - 20 of 73
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
7 May 5:42 pm
... producers in order to provide most of their viewing content to their audiences. If the acquisition of the company by another corporation were to allow the television producers to terminate the programming agreements, the company's broadcast stations may go off the ... of the surviving Schering corporation after step two, they indirectly will have already taken the helm of the surviving Schering corporation through the election of their own directors to the new parent company's board. In our next ...
Private Equity Law Review - http://www.privateequitylawreview.com/
11 May 7:01 pm
... than the [board of directors]" (emphasis added). The drafters of this clause probably intended it to prohibit extraordinary changes to Schering's board of directors resulting from tender offers or other hostile takeover techniques. Nevertheless, we do not ... board. Remember, Schering has agreed to put Merck's board of directors in control of the surviving Schering corporation before Merck becomes Schering's subsidiary in the second and final step of the merger. The inevitable negotiations between ...
Private Equity Law Review - http://www.privateequitylawreview.com/
19 Mar 2:18 pm
... Introduction On March 9, 2009 Merck Co., Inc. ("Merck") and Schering-Plough Corporation ("Schering-Plough") announced that a merger agreement had been unanimously approved ... drug rights to Remicade will not be lost. II. Background In its merger, Merck and Schering-Plough devised a unique reverse merger. In the following section, the reverse merger will be analyzed ... advantageous. [1] Press Release, Merck & Co., Inc, Merck and Schering-Plough to Merge, Mar. 9, 2009. [2] Val Brickates Kennedy & ...
The Journal of the Business Law Society - http://www.law.uiuc.edu/bljournal/
20 May, 2008 4:24 am by Peter Rost
Susan Ellen Wolf, Corporate Secretary, Vice President Governance and Associate General Counsel of Schering-Plough has been posting messages on numerous pharma blogs (Pharmalot, WSJ, Forbes) after Forbes raised the question if ... to communicate. The only conclusion is that Mr. Hassan is very worried that people will ask him to return some of the money he took from Schering-Plough.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy.
THE PHARMA LAW BLOG - http://peterrost.blogspot.com/
12 May 3:34 am by Vanessa Vidal, Esq.
... Wyeth Mergers, Restructurings, and Bankruptcies Contributing to Layoffs. Mergers, restructurings, and bankruptcies are also contributing to corporate legal department layoffs. The pharmaceutical industry has been particularly active on the merger front, embarking on gigantic ... will, and some already have, resulted in corporate legal department redundancies and layoffs. Oracle/Sun Microsystems Pfizer/Wyeth Roche Holding/Genentech Merck/Schering-Plough Gilead Sciences/CV Therapeutics Financial ...
InHouse Insider - http://www.inhouseinsider.com/
12 Mar, 2007 9:42 pm by Donald Zuhn
By Donald Zuhn --- Schering-Plough Corporation announced on March 12th that its Board of Directors has approved the purchase of Organon BioSciences N.V. from Akzo Nobel N.V. for US $14.4 billion. Schering-Plough chairman and CEO Fred Hassan noted that the acquisition would give Schering-Plough immediate access to central nervous system...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
29 Oct, 2008 3:23 pm by RiskMetrics Group Blog Team
... 2006 with the shareholder survey on majority voting for directors" said Pat Russo, Chair of the Nominating and Corporate Governance Committee of the Board, in the company's press release. Indeed, the company conducted a shareholder survey on ... according to the release. Koppes also will serve as the conduit for shareholders wishing to respond to the survey on a confidential basis. Schering-Plough has participated in the Working Group exploring the issue of "say on pay" and presumably is hoping to ...
Institutional Shareholder Services -- Corporate Governance Blog - http://blog.issproxy.com/
14 Nov, 2008 1:15 pm by J. Robert Brown
We have been a bit remiss for failing to note sooner the post over at RiskMetrics on the Schering-Plough decision to make an effort at systematically improving communications with shareholders. The company has done so by circulating a survey ... did in 2006 with the shareholder survey on majority voting for directors said Pat Russo, Chair of the Nominating and Corporate Governance Committee of the Board, in the company's press release. Indeed, the company conducted a shareholder survey on governance ...
The Race to the Bottom - http://www.theracetothebottom.org/home/
11 Dec, 2006 4:27 am by Phil
... : Late last June the United States Supreme Court rejected an opportunity to review the decision of the 11th Circuit Court of Appeals in Schering-Plough Corporation v. Federal Trade Commission, 402 F. 3d 1056 (11th Cir. 2005). In that case the Circuit Court overturned the decision by the FTC finding that several settlements entered into by Schering-Plough with generic drug competitors that involved "reverse payments" by S-P to the generic producers as part of a settlement limiting ...
Tags: Reverse, Payments
Philip Brooks' Patent Infringement Updates - http://infringement.blogs.com/philip_brooks_patent_infr/
19 May, 2008 6:56 am by Peter Rost
My, my a Vice President Governance and Associate General Counsel Schering-Plough caught spreading untruthful information? Or is it the 2007 Schering-Plough proxy that is untruthful? Something for the SEC? Story on Scherlings got Plowed.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy.
THE PHARMA LAW BLOG - http://peterrost.blogspot.com/
6 Aug 8:40 am by Andy Hoffman
... negative…what a catchy old song! And apparently, about 140 claimants could just imagine the execs at Merck and Schering-Plough humming along, as they buried (for about two years) an unfavorable study that showed the companies' jointly marketed cholesterol ... yet another story about drug companies accused of burying unfavorable (i.e., bad for profits) test results, Merck and Schering-Plough have agreed to a $41.5 million settlement (without admitting any wrongdoing), resolving 140 claims brought by ...
ThePopTort - http://www.thepoptort.com/
24 Mar 5:22 am by Vanessa Vidal, Esq.
... ! Inc. Mergers, Restructurings, and Bankruptcies Contributing to Layoffs. Mergers, restructurings, and bankruptcies are also contributing to corporate legal department layoffs. The pharmaceutical industry has been particularly active on the merger front, embarking on gigantic ... big mergers will, and some already have, resulted in corporate legal department redundancies and layoffs. Pfizer/Wyeth Roche Holding/Genentech Merck/Schering-Plough Gilead Sciences/CV Therapeutics Financial companies have ...
InHouse Insider - http://www.inhouseinsider.com/
9 Mar 4:44 am by Peter Rost
... million even though two of them had "below-target performance," according to a Merck filing with the SEC. They also got to use the corporate jet, and so did their wives. The largesse came despite the fact that Merck's sales declined 3 percent from ... Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth. You'll notice that list contains 14 companies - an even number. This means that there ...
THE PHARMA LAW BLOG - http://peterrost.blogspot.com/
7 Sep, 2006 9:46 pm by Joe Hodnicki
From Taipeitimes.com: What do ATT, Boeing, Com-verse Technology, Prudential Financial, Medtronic, Schering-Plough and Tenet Healthcare have in common? In recent months, they have all been charged with fraudulent conduct by the US Justice Department's Corporate Fraud Task Force, or with...
Tags: White, Collar
CrimProf Blog - http://lawprofessors.typepad.com/crimprof_blog/
9 Apr 6:24 am by admin
... the former sales representatives were non-exempt employees entitled to overtime payment. In the complaint, the employees alleged that their employer, Schering Corporation ("Schering") misclassified them as "exempt" employees and as a result, failed to pay them overtime wages in violation of the FLSA. In response to the allegations, Schering argued that the former employees were pharmaceutical sales representatives and thus, fell within the FLSA's outside sales ...
Unpaid Overtime Blog - http://unpaidovertimeblog.com
2 Jul 6:01 pm by Phil
... release at Webwire: Bayer Schering Pharma AG, Germany and Bayer HealthCare Pharmaceuticals Inc. together with Schering Corporation have filed a patent infringement lawsuit in the U.S. Federal Court in the District of Delaware against Teva Pharmaceuticals ... , Ltd.. The lawsuit concerns Teva's application to the FDA for approval to market a generic form of Levitra®, Bayer Schering Pharma's therapy for the treatment of erectile dysfunction, prior to patent expiration. The patent at issue in the suit ...
Philip Brooks' Patent Infringement Updates - http://infringement.blogs.com/philip_brooks_patent_infr/
9 Oct 9:11 am by Karen E. Keller
... Pharmaceuticals Inc. (patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc., Schering Corporation v. Teva Pharmaceuticals USA, Inc. and Teva ... . and NICE Systems Ltd. (patent infringement) 9/17: US Philips Corporation v. Samsung Electronics Company Ltd. and Samsung Electronics America Inc. ... : St. Clair Intellectual Property Consultants Inc. v. Apple Inc., Toshiba Corporation, Toshiba America Information Systems, Inc. and Tohsiba America, Inc. (patent infringement ...
Delaware IP Law Blog - http://www.delawareiplaw.com/
1 Apr 3:36 am by Andrew Frisch
Kuzinski v. Schering Corp. Plaintiffs initiated this suit against Schering Corporation, their former employer, for relief from Defendant's alleged misclassification of them as "exempt" employees resulting in its failure to pay them overtime wages, in violation of the Fair Labor Standards Act (FLSA), 29 U.S.C. §§ 201 et seq. Defendant moved for summary judgment on the [...]
Overtime Law Blog | FLSA Decisions - http://overtimelaw.wordpress.com
9 Nov 1:01 am by Peter Rost
... its good standing with such agencies because its subsidiaries, Warner-Lambert and P&U, and not the corporation itself, entered the guilty pleas to felony charges. A felony conviction of a pharmaceutical giant could lead to disaster for ... at the center of its work. "With this agreement, we are putting issues from the past behind us," he said. Schering declined to comment further. As prosecutors continue to uncover patterns of deceit in off-label marketing by pharmaceutical companies, millions ...
THE PHARMA LAW BLOG - http://peterrost.blogspot.com/
2 Nov 9:57 am by John W. Arden
... -Plough's Acquisition of Merck This posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter. Schering-Plough Corporation can proceed with its proposed $41.1 billion acquisition of Merck & Co. Inc. under the terms ... Bureau Approval Canada's Competition Bureau also announced on October 29 that it has reached an agreement with Merck and Schering-Plough to resolve competition concerns with respect to their proposed merger. The Competition Bureau said that it worked closely with ...
Trade Regulation Talk - http://traderegulation.blogspot.com/
        Next >
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck